Foghorn Therapeutics Inc. (FHTX) financial statements (2022 and earlier)

Company profile

Business Address 500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments101,13657,841125,16666,44992,79574,620
Cash and cash equivalents101,13657,841125,16666,44992,79574,620
Restricted cash and investments     541
Deferred costs     2,000
Other undisclosed current assets358,42666,11219,50698,86697,892603
Total current assets:459,562123,953144,672165,315190,68777,764
Noncurrent Assets
Finance lease, right-of-use asset  400400  
Operating lease, right-of-use asset38,51639,60640,67441,74242,80443,902
Property, plant and equipment    19,52816,848
Restricted cash and investments1,7331,7331,7331,7331,7331,733
Deferred costs     1,970
Other noncurrent assets2,4002,4312,4451,603842211
Other undisclosed noncurrent assets17,56318,34618,60219,093  
Total noncurrent assets:60,21262,11663,85464,57164,90764,664
TOTAL ASSETS:519,774186,069208,526229,886255,594142,428
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,3817,9518,5588,03712,84113,524
Accounts payable3,8193,8213,4062,9113,6803,554
Accrued liabilities9,5628885,1525,1269,1619,970
Employee-related liabilities 3,242    
Deferred revenue28,3171,2789102,4072,0241,696
Debt  106105 5,990
Other undisclosed current liabilities6,99410,0676,8405,7833,98191
Total current liabilities:48,69219,29616,41416,33218,84621,301
Noncurrent Liabilities
Long-term debt and lease obligation51,33873,02075,00176,77378,01564,806
Long-term debt, excluding current maturities 20,00020,00020,00019,6548,801
Finance lease, liability  198225  
Operating lease, liability51,33853,02054,80356,54858,36156,005
Liabilities, other than long-term debt322,87312,85713,09511,87812,54613,125
Deferred revenue322,73012,68613,09511,87812,54613,125
Other liabilities143171    
Other undisclosed noncurrent liabilities (86)(174)(261) 114
Total noncurrent liabilities:374,21185,79187,92288,39090,56178,045
Total liabilities:422,903105,087104,336104,722109,40799,346
Temporary equity, carrying amount     176,405
Stockholders' equity
Stockholders' equity attributable to parent96,87180,982104,190125,164146,187(133,323)
Common stock444441
Additional paid in capital361,133316,104313,229311,076309,1268,854
Accumulated other comprehensive income (loss)(10)(13)(10)6(7) 
Accumulated deficit(264,256)(235,113)(209,033)(185,922)(162,936)(142,178)
Total stockholders' equity:96,87180,982104,190125,164146,187(133,323)
TOTAL LIABILITIES AND EQUITY:519,774186,069208,526229,886255,594142,428

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Revenues600700600600251179
Sublease income600700600600  
Gross profit:600700600600251179
Operating expenses(28,795)(26,302)(23,540)(23,416)(21,030)(18,668)
Other undisclosed operating income (loss)113(659)(321)(314)  
Operating loss:(28,082)(26,261)(23,261)(23,130)(20,779)(18,489)
Nonoperating income (expense)(1,061)18115014421122
Interest and debt expense247(499)(495)(486)(543)(202)
Loss before gain (loss) on sale of properties:(28,896)(26,579)(23,606)(23,472)(21,301)(18,569)
Other undisclosed net income    543 
Net loss:(28,896)(26,579)(23,606)(23,472)(20,758)(18,569)
Other undisclosed net income (loss) attributable to parent(247)499495486 202
Net loss available to common stockholders, diluted:(29,143)(26,080)(23,111)(22,986)(20,758)(18,367)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Net loss:(28,896)(26,579)(23,606)(23,472)(20,758)(18,569)
Comprehensive loss:(28,896)(26,579)(23,606)(23,472)(20,758)(18,569)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(244)496479499(7) 
Comprehensive loss, net of tax, attributable to parent:(29,140)(26,083)(23,127)(22,973)(20,765)(18,569)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: